Researchers have created microscopic robots that can deliver painkillers and cancer drugs, and even eat up artery-clogging cholesterol inside the body. Here’s the best way to play the rise of medical minibots for double-digit profits.
Read More
This week’s Capital One hack spotlights the need to take precautions against cyber thieves. But it also highlights a great investment strategy that leverages a fintech fix — blockchain technology — that could mean the end of risky credit card and bank account hacks.
Read More
Small biotech startups are beating Big Pharma to the punch in developing new “precision medicine” drugs, fueling a wave of 2019 mergers and acquisitions. Here’s the best way to play the biotech-pharma merger mania for double-digit profits.
Read More
Last year was a high-water mark for biotech companies going public — with 60. But the Class of 2019 is on track to beat that record, with 38 biotech IPOs since January 1. Here’s how to capitalize on the red-hot biotech IPO market.
Read More
Today, Bold Profits IPO analyst Hudson Cashdan talks up the new Chewy public offering and tells Nick Tate why Beyond Meat has been such a superstar stock since going public on May 1. Plus: a preview of Bold Profits’ new IPO Speculator service.
Read More
Editor of Real Wealth Strategist and Front Line Profits
Editor of The Bauman Letter and Alpha Stock Alert
Senior Managing Editor
Editor of Peak Velocity Trader and Precision Profits
Editor of Great Stuff
Editor of Profits Unlimited and four elite trading services
Editor of Insider Profit Trader
Editor of Pure Income and Automatic Profits Alert
Editor of Total Wealth Insider and Insider Profit Trader
Assistant Managing Editor
Internal Analyst
Editor of Alpha Investor Report
Senior Editorial Manager
Editor of Rapid Profit Trader and The $10 Million Portfolio
Director of Investment Research
Senior Analyst
Analyst for IPO Speculator
Editor of Automatic Fortunes and Crypto Profit Trader
Editorial Director
Legal Counsel, Chairman of Freedom Alliance
